Cell line · CVCL_2025
DuCaP
Cancer cell line, Homo sapiens. Prostate carcinoma. 10 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. DuCaP. Cell lines, record CVCL_2025. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_2025
On this page
Cell line
As Cellosaurus gives it.
- Name
- DuCaP
- Accession
- CVCL_2025
- RRID
- RRID:CVCL_2025
- Synonyms
- DUCaP, Ducap, Dura mater Cancer of the Prostate
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 59Y
- Category
- Cancer cell line
- Diseases
- Prostate carcinoma (NCIt C4863)
- Derived from
- Brain, meningeal dura mater (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2024-12-19
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers10
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Rapid Decentralized Prostate Cancer Risk Stratification by Portable Liquid Biopsy Analysis within a Clinical Biosensor Validation Framework. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dampened Regulatory Circuitry of TEAD1/ITGA1/ITGA2 Promotes TGFβ1 Signaling to Orchestrate Prostate Cancer Progression. | Adv Sci (Weinh) | 2024 | Its Methods give the RRID and name the line | PubMed | |
| AKR1C3 Converts Castrate and Post-Abiraterone DHEA-S into Testosterone to Stimulate Growth of Prostate Cancer Cells via 5-Androstene-3β,17β-Diol. | Cancer Res Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Gene expression based inference of cancer drug sensitivity. | Nat Commun | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer. | Int J Cancer | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus. | Cell | 2018 | Its Methods give the RRID and name the line | PubMed | |
| Models for prostate cancer. Molecular characterization and critical appraisal of human prostate carcinoma cell lines. | 2004 | Cellosaurus cites it | Cellosaurus | ||
| Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines. | Prostate | 2003 | Cellosaurus cites it | PubMed | |
| Molecular characterization of human prostate carcinoma cell lines. | Prostate | 2003 | Cellosaurus cites it | PubMed | |
| Establishment and characterization of a new human prostatic cancer cell line: DuCaP. | In Vivo | 2001 | Cellosaurus cites it | PubMed |
Relatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| From the same person | VCaP | CVCL_2235 |
Source Cell lines
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_2025
GET https://conductscience.org/api/cell-lines/v1/CVCL_2025/problems